Leelawat S, Leelawat K
J Trop Med. 2018; 2018:6854835.
PMID: 29973956
PMC: 6008724.
DOI: 10.1155/2018/6854835.
Polycarpou A, Walker S, Lockwood D
Front Immunol. 2017; 8:233.
PMID: 28348555
PMC: 5346883.
DOI: 10.3389/fimmu.2017.00233.
Nelson D, Nelson M, THURSTON J, Waters M, Pearson J
Clin Exp Immunol. 1971; 9(1):33-43.
PMID: 5559093
PMC: 1712991.
Rees R
Postgrad Med J. 1970; 46(538):486-90.
PMID: 5481097
PMC: 2467272.
DOI: 10.1136/pgmj.46.538.486.
Turk J
Br Med J. 1970; 3(5719):363-8.
PMID: 5451586
PMC: 1701292.
DOI: 10.1136/bmj.3.5719.363.
Immunological problems in leprosy research. 1. Clinical and pathological spectrum of leprosy.
Bull World Health Organ. 1970; 43(6):879-90.
PMID: 5314019
PMC: 2427818.
A study of cell mediated immunity in leprosy: changing trends in the immunological spectrum of the disease.
Saha K, Mittal M
Clin Exp Immunol. 1971; 8(6):901-9.
PMID: 5091616
PMC: 1713046.
Impairment of cell-mediated immune responses by Pseudomonas aeruginosa.
FLOERSHEIM G, Hopff W, Gasser M, Bucher K
Clin Exp Immunol. 1971; 9(2):241-7.
PMID: 4998926
PMC: 1713021.
Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.
Godal T, MYKLESTAD B, Samuel D, Myrvang B
Clin Exp Immunol. 1971; 9(6):821-31.
PMID: 4945738
PMC: 1713129.
Immunological significance of changes in lymph nodes across the leprosy spectrum.
Turk J, Waters M
Clin Exp Immunol. 1971; 8(3):363-76.
PMID: 4930640
PMC: 1712922.
Cell-mediated immunological processes in leprosy.
Turk J
Bull World Health Organ. 1969; 41(6):779-92.
PMID: 4908550
PMC: 2427593.
DOI: 10.5935/0305-7518.19700030.
Attempts to convert lepromatous into tuberculoid-type leprosy with blood lymphocyte extracts from sensitized donors.
Silva C, Lima A, Andrade L, MATTOS O
Clin Exp Immunol. 1973; 15(1):87-92.
PMID: 4765722
PMC: 1553871.
The primary immune response to haemocyanin in patients with primary biliary cirrhosis.
Fox R, DUDLEY F, Sherlock S
Clin Exp Immunol. 1973; 14(4):473-80.
PMID: 4747579
PMC: 1553816.
Quantitative dinitrochlorobenzene contact sensitization in a normal population.
Catalona W, Taylor P, Chretien P
Clin Exp Immunol. 1972; 12(3):325-33.
PMID: 4642908
PMC: 1553595.
Presence of C1q-reactive immune complexes in patients with leprosy.
Rojas-Espinosa O, Estrada-Parra S
Clin Exp Immunol. 1972; 12(2):215-23.
PMID: 4630778
PMC: 1553577.
Evaluation of cell mediated immune responses in untreated cases of leprosy.
Talwar G, Krishnan A, Mehra V, Blum E, Pearson J
Clin Exp Immunol. 1972; 12(2):195-203.
PMID: 4567646
PMC: 1553575.
Thymus-dependent lymphocytes of peripheral blood in leprosy patients.
Lim S, Kiszkiss D, Jacobson R, Choi Y, GOOD R
Infect Immun. 1974; 9(2):394-9.
PMID: 4544619
PMC: 414815.
DOI: 10.1128/iai.9.2.394-399.1974.
Host responses to Epstein-Barr virus and cytomegalovirus infection in leprosy.
Papageorgiou P, Sorokin C, Kouzoutzakoglou K, Bonforte R, Workman P, Glade P
Infect Immun. 1973; 7(4):620-4.
PMID: 4357604
PMC: 422734.
DOI: 10.1128/iai.7.4.620-624.1973.
Heterologous specific antiserum for identification of human T lymphocytes.
Touraine J, Touraine F, Kiszkiss D, Choi Y, GOOD R
Clin Exp Immunol. 1974; 16(4):503-20.
PMID: 4143194
PMC: 1553996.
[Clinical-immunological and electron microscopic findings in Whipple's diseases (author's transl)].
Buchholz K, Maintz J, Otto H
Klin Wochenschr. 1974; 52(14):672-7.
PMID: 4138641
DOI: 10.1007/BF01468478.
